{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:16:58Z","timestamp":1788556618595,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["216593\/Z\/19\/Z"],"award-info":[{"award-number":["216593\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/X511353\/1"],"award-info":[{"award-number":["BB\/X511353\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omta.2025.201652","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T16:08:03Z","timestamp":1766765283000},"page":"201652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-existing retinal inflammation exacerbates gene therapy-associated uveitis in more rapidly progressive retinal degeneration"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5924-1672","authenticated-orcid":false,"given":"Molly C.","family":"John","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Martinez-Fernandez de la Camara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Staurenghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Shamsnajafabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle E.","family":"McClements","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Cehajic-Kapetanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Dominik","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"MacLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanmin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2025.201652_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/biom14010122","article-title":"Real-World Safety and Effectiveness of Voretigene Neparvovec: Results up to 2 Years from the Prospective, Registry-Based PERCEIVE Study","volume":"14","author":"Fischer","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.omta.2025.201652_bib2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2025.201652_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber\u2019s congenital amaurosis is safe and effective through 1.5 years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2025.201652_bib4","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMoa0802315","article-title":"Safety and efficacy of gene transfer for Leber\u2019s congenital amaurosis","volume":"358","author":"Maguire","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2025.201652_bib5","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/s41591-018-0185-5","article-title":"Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia","volume":"24","author":"Xue","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2025.201652_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41591-020-0763-1","article-title":"Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR","volume":"26","author":"Cehajic-Kapetanovic","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.omta.2025.201652_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0140-6736(24)02812-5","article-title":"Gene therapy in children with AIPL1-associated severe retinal dystrophy: an open-label, first-in-human interventional study","volume":"405","author":"Michaelides","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.omta.2025.201652_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s40291-024-00722-0","article-title":"Gene Therapies in Clinical Development to Treat Retinal Disorders","volume":"28","author":"McClements","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.omta.2025.201652_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2025.101354","article-title":"Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy","volume":"106","author":"Purdy","year":"2025","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omta.2025.201652_bib10","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-Term Effect of Gene Therapy on Leber\u2019s Congenital Amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omta.2025.201652_bib11","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1016\/j.ymthe.2017.08.018","article-title":"AAV8 Can Induce Innate and Adaptive Immune Response in the Primate Eye","volume":"25","author":"Reichel","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2025.201652_bib12","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/bjophthalmol-2021-321023","article-title":"Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec","volume":"107","author":"Reichel","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.omta.2025.201652_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100516","article-title":"Dose-Dependent Progression of Chorioretinal Atrophy at the Injection Site After Subretinal Injection of rAAV2\/8 in Nonhuman Primates","volume":"4","author":"Seitz","year":"2024","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.omta.2025.201652_bib14","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.3390\/ijms22042096","article-title":"Retinal Inflammation, Cell Death and Inherited Retinal Dystrophies","volume":"22","author":"Olivares-Gonz\u00e1lez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2025.201652_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-319-75402-4_23","article-title":"Neuroinflammation in Retinitis Pigmentosa, Diabetic Retinopathy, and Age-Related Macular Degeneration: A Minireview","volume":"1074","author":"Massengill","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omta.2025.201652_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1177711","article-title":"The double-edged sword of inflammation in inherited retinal degenerations: Clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications","volume":"11","author":"Sarici","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omta.2025.201652_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.672444","article-title":"Importance of Autoimmune Responses in Progression of Retinal Degeneration Initiated by Gene Mutations","volume":"8","author":"Adamus","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.omta.2025.201652_bib18","article-title":"Changes of serum inflammatory molecules and their relationships with visual function in retinitis pigmentosa","volume":"61","author":"Okita","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2025.201652_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/aos.13899","article-title":"Intraocular cytokine profile and autoimmune reactions in retinitis pigmentosa, age-related macular degeneration, glaucoma and cataract","volume":"97","author":"Ten Berge","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.omta.2025.201652_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ophtha.2012.07.006","article-title":"Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa","volume":"120","author":"Yoshida","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omta.2025.201652_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177224","article-title":"Strong upregulation of inflammatory genes accompanies photoreceptor demise in canine models of retinal degeneration","volume":"12","author":"Appelbaum","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2025.201652_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.preteyeres.2018.10.003","article-title":"Immune regulation in the aging retina","volume":"69","author":"Chen","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omta.2025.201652_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-065X.2006.00439.x","article-title":"Ocular autoimmunity: The price of privilege?","volume":"213","author":"Caspi","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omta.2025.201652_bib24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1089\/hum.2022.159","article-title":"Update on Viral Gene Therapy Clinical Trials for Retinal Diseases","volume":"33","author":"Cheng","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2025.201652_bib25","first-page":"352","article-title":"Phase 1 Study of Intravitreal Gene Therapy with ADVM-022 for neovascular AMD (OPTIC Trial)","volume":"62","author":"Busbee","year":"2021","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2025.201652_bib26","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.3390\/cells11213362","article-title":"Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications","volume":"11","author":"Zhang","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.omta.2025.201652_bib27","first-page":"5312","article-title":"Meta-analysis of Gene Therapy Associated Uveitis (GTAU)","volume":"65","author":"Buckley","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2025.201652_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.omtm.2021.05.011","article-title":"Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina","volume":"22","author":"Chandler","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omta.2025.201652_bib29","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1073\/pnas.97.7.3649","article-title":"A retinitis pigmentosa GTPase regulator (RPGR)- deficient mouse model for X-linked retinitis pigmentosa (RP3)","volume":"97","author":"Hong","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2025.201652_bib30","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208707119","article-title":"Impaired glutamylation of RPGRORF15 underlies the cone-dominated phenotype associated with truncating distal ORF15 variants","volume":"119","author":"Cehajic-Kapetanovic","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2025.201652_bib31","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/13816810.2022.2083181","article-title":"The first reported case of a deletion of the entire RPGR gene in a family with X-linked retinitis pigmentosa","volume":"43","author":"Mihailovic","year":"2022","journal-title":"Ophthalmic Genet."},{"key":"10.1016\/j.omta.2025.201652_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1167\/iovs.61.14.36","article-title":"Spectrum of Disease Severity in Patients With X-Linked Retinitis Pigmentosa Due to RPGR Mutations","volume":"61","author":"Di Iorio","year":"2020","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omta.2025.201652_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.visres.2023.108268","article-title":"Microglial and macroglial dynamics in a model of retinitis pigmentosa","volume":"210","author":"D\u00edaz-Lezama","year":"2023","journal-title":"Vision Res"},{"key":"10.1016\/j.omta.2025.201652_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.preteyeres.2009.07.001","article-title":"Cellular signaling and factors involved in M\u00fcller cell gliosis: neuroprotective and detrimental effects","volume":"28","author":"Bringmann","year":"2009","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omta.2025.201652_bib35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1089\/hum.2020.213","article-title":"Genetic Rescue of X-Linked Retinoschisis Mouse (Rs1\u2212\/y) Retina Induces Quiescence of the Retinal Microglial Inflammatory State Following AAV8-RS1 Gene Transfer and Identifies Gene Networks Underlying Retinal Recovery","volume":"32","author":"Vijayasarathy","year":"2021","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omta.2025.201652_bib36","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ophtha.2024.02.023","article-title":"Assessment of Visual Function with Cotoretigene Toliparvovec in X-Linked Retinitis Pigmentosa in the Randomized XIRIUS Phase 2\/3 Study","volume":"131","author":"Lam","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omta.2025.201652_bib37","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.ymthe.2017.05.005","article-title":"Codon-Optimized RPGR Improves Stability and Efficacy of AAV8 Gene Therapy in Two Mouse Models of X-Linked Retinitis Pigmentosa","volume":"25","author":"Fischer","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2025.201652_bib38","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1189\/jlb.0207114","article-title":"Microglia activation in retinal degeneration","volume":"81","author":"Langmann","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.omta.2025.201652_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pneurobio.2018.05.006","article-title":"Retinal microglia \u2013 A key player in healthy and diseased retina","volume":"173","author":"Rathnasamy","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.omta.2025.201652_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of General and Discriminating Markers of Differential Microglia Phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.omta.2025.201652_bib41","doi-asserted-by":"crossref","first-page":"20636","DOI":"10.1038\/srep20636","article-title":"Fate mapping reveals that microglia and recruited monocyte-derived macrophages are definitively distinguishable by phenotype in the retina","volume":"6","author":"O\u2019Koren","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omta.2025.201652_bib42","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.immuni.2019.02.007","article-title":"Microglial Function Is Distinct in Different Anatomical Locations during Retinal Homeostasis and Degeneration","volume":"50","author":"O\u2019Koren","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.omta.2025.201652_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120415","article-title":"M\u00fcller Glia Activation in Response to Inherited Retinal Degeneration Is Highly Varied and Disease-Specific","volume":"10","author":"Hippert","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2025.201652_bib44","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-3-319-75402-4_37","article-title":"M\u00fcller Glia Reactivity and Development of Gliosis in Response to Pathological Conditions","volume":"1074","author":"Graca","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omta.2025.201652_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052591","article-title":"Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders","volume":"23","author":"Mahaling","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2025.201652_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev-vision-121219-081730","article-title":"Microglia Activation and Inflammation during the Death of Mammalian Photoreceptors","volume":"6","author":"Karlen","year":"2020","journal-title":"Annu. Rev. Vis. Sci."},{"key":"10.1016\/j.omta.2025.201652_bib47","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nri3521","article-title":"The speed of change: towards a discontinuity theory of immunity?","volume":"13","author":"Pradeu","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omta.2025.201652_bib48","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.ymthe.2025.01.028","article-title":"Characterization of the ocular inflammatory response to AAV reveals divergence by sex and age","volume":"33","author":"Clare","year":"2025","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X25000023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X25000023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:11:35Z","timestamp":1788556295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X25000023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3117387X25000023"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2025.201652","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-existing retinal inflammation exacerbates gene therapy-associated uveitis in more rapidly progressive retinal degeneration","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2025.201652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201652"}}